BSAC Respiratory Resistance Surveillance Programme (2002-2003): comparative susceptibility of Streptococcus pneumoniae, cultured from patients in Great Britain and Ireland with community-acquired lower respiratory tract infection, to gemifloxacin.
Felmingham
David
D
Shackcloth
Jemma
J
Tillotson
Glenn
G
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial; D024841:Fluoroquinolones / Q000494:pharmacology*; D000077735:Gemifloxacin; D006801:Humans; D007494:Ireland; D009287:Naphthyridines / Q000494:pharmacology*; D011008:Pneumococcal Infections / Q000382:microbiology*; D011159:Population Surveillance; D012141:Respiratory Tract Infections / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000187:drug effects*; D006113:United Kingdom
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; D000077735:Gemifloxacin